Drug Screening Market, By Product & Services (Equipment, Liquid Analytical Instruments, Rapid Testing Devices (RTD), Consumables, and Drug Screening), By Sample Type, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4051
|
Published Date
June 2025
|
Pages
377
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Drug Screening Market size was valued at US$ 8,234.54 Million in 2024, expanding at a CAGR of 16.5% from 2025 to 2032.
Drug screening involves analyzing biological samples to detect the presence of specific illicit substances, prescription medications, and their metabolites. This testing plays a crucial role in crime detection, workplace safety, pre-employment verification, forensic investigations, medical diagnostics, and monitoring patient recovery from substance abuse. The choice of biological sample—such as urine, blood, hair, oral fluid (saliva), or breath—depends on the drug being tested, the required turnaround time, and the testing environment. Among these, urine drug testing remains the preferred method due to its simplicity, non-invasiveness, and high sensitivity to a wide range of substances. Its primary purpose is to identify substance use, ensure public safety and regulatory compliance, protect vulnerable populations, and support interventions for substance abuse.
Drug Screening Market- Market Dynamics
The global drug screening market is experiencing rapid growth driven by several key factors. A primary driver is the increasing prevalence of drug and alcohol use worldwide. According to the United Nations Office on Drugs and Crime (UNODC), approximately 296 million people used drugs in 2021, marking a 23% increase over the past decade. This rise in substance abuse has led to a greater demand for regular drug testing across multiple sectors. In regions such as North America and Europe, stricter regulations governing drug and alcohol testing in workplaces, the criminal justice system, and transportation industries have further fueled market growth. For example, the U.S. Department of Transportation (DOT) enforces mandatory drug and alcohol testing for safety-sensitive employees, sustaining a consistent need for these services.
Significant opportunities in the market revolve around oral fluid testing and at-home testing kits. Oral fluid sampling offers a convenient, less invasive method with a reduced risk of tampering, delivering rapid results within minutes, which enhances its appeal for on-the-spot screening. Additionally, drug testing among pain management patients is becoming increasingly important for monitoring compliance and detecting misuse. The legalization of cannabis in various regions introduces new challenges that demand more sophisticated testing methods to ensure safety. Emerging healthcare markets and growing awareness of substance abuse in developing countries present untapped growth potential. However, concerns over personal privacy and ethical issues related to mandatory drug testing could hinder market expansion, particularly in regions with stringent privacy laws. Furthermore, challenges such as sample contamination and the use of masking agents continue to complicate test accuracy, making validity testing a persistent concern.
Drug Screening Market- Key Insights
- Consumables hold the largest market share, primarily because these items—such as assay kits, reagents, sample collection devices, calibrators, and controls—are single-use for each test, resulting in consistent and recurring demand.
- Rapid Testing Devices (RTDs) are experiencing the fastest growth due to their ability to deliver quick results. Their portability and ease of use make them especially popular in workplaces, law enforcement settings, and hospitals.
- Drug Testing Laboratories command the largest market share owing to their advanced equipment and skilled personnel. These laboratories are the preferred choice for comprehensive and court-approved drug testing, particularly for complex forensic and medical cases.
- The workplace segment is projected to be the fastest-growing during the forecast period. Increasing emphasis on workplace safety, risk reduction, improved employee performance, and regulatory compliance is driving demand for pre-employment, random, and post-incident drug testing.
- North America leads the drug screening market, supported by stringent drug screening regulations, a high prevalence of illicit drug use, extensive government anti-drug initiatives, prominent industry players, and well-established healthcare infrastructure.
Drug Screening Market- Segmentation Analysis:
The Global Drug Screening Market is segmented on the basis of Product & Services, Sample Type, End User, and Region.
The drug testing market, segmented by product and services, includes equipment, liquid analytical instruments, rapid testing devices (RTDs), consumables, analytical instruments, and laboratory services. Among these, the consumables segment holds the largest market share. This dominance is primarily because drug testing relies heavily on single-use consumables that require constant replenishment. Consumables encompass a wide range of products such as assay kits, reagents, standard samples, control materials, urine cups, oral fluid swabs, and hair collection kits. Government regulations and guidelines, such as those issued by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), mandate the use of standardized consumables to ensure accuracy and reliability in drug testing protocols, further fueling demand. Additionally, ongoing investments by government agencies to improve public safety and workplace drug testing programs sustain the consumption of these essential products.
Rapid testing devices (RTDs) represent the fastest-growing segment within the drug testing market. The surge in demand for quick, convenient, and on-site drug testing solutions is the key driver behind this growth. RTDs, including instant urine cups and oral fluid devices, provide results within minutes without requiring bulky laboratory equipment. Their ease of use and rapid turnaround make them especially valuable for workplace drug testing, roadside sobriety checks by law enforcement, and emergency room diagnostics. Government initiatives to strengthen roadside drug detection and workplace safety regulations, such as the U.S. Department of Transportation’s drug testing programs, have accelerated adoption of RTDs, emphasizing the need for swift and reliable screening tools to curb drug-impaired driving and workplace accidents.
By end user, drug testing laboratories command the largest share of the market. These laboratories are equipped with advanced technologies like gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS), which are critical for confirmatory testing due to their high accuracy and reliability. Laboratories play a crucial role not only in processing large volumes of samples but also in ensuring the integrity and legal defensibility of results through strict chain-of-custody protocols. Regulatory frameworks and accreditation standards set by bodies such as the College of American Pathologists (CAP) and the Clinical Laboratory Improvement Amendments (CLIA) reinforce the importance of laboratories in maintaining testing quality and forensic validity, particularly for criminal justice and employment drug screening programs.
The workplace and schools segment is projected to experience the fastest growth during the forecast period. Increasingly, employers are adopting drug testing policies for pre-employment screening, random testing, post-incident checks, and suspicion-based testing to mitigate risks related to impaired judgment, workplace accidents, and decreased productivity. Concurrently, educational institutions, including schools and colleges, are implementing drug screening programs to promote safer learning environments and comply with regulatory requirements such as the Drug-Free Schools and Communities Act (DFSCA) in the United States. Government campaigns highlighting the negative impact of drug and alcohol abuse on workforce performance and student safety are major drivers behind the expanding adoption of drug testing in these sectors.
Drug Screening Market- Geographical Insights
North America holds the largest share of the drug screening market, primarily driven by a robust regulatory framework—especially in the US and Canada—that mandates drug and alcohol testing across various sectors, including transportation, federal employment, and safety-sensitive occupations. The region’s growth is further supported by the presence of major market players, world-class healthcare infrastructure, and substantial government funding aimed at preventing and treating substance abuse. Globally, governments are significantly increasing investments in substance abuse prevention and testing programs, with recent reports indicating that over 60% of countries have implemented or are expanding mandatory drug screening policies to enhance public safety and workplace compliance.
The Asia-Pacific region is expected to witness the fastest market growth. This expansion is fueled by increasing awareness of substance abuse issues, improvements in healthcare infrastructure, and the gradual implementation of stringent drug testing regulations in countries such as China, India, and Australia. Additionally, rising industrialization and globalization have heightened the focus on workplace safety and productivity, prompting more companies to adopt drug screening programs. Growing disposable incomes and better access to healthcare services in these emerging economies also facilitate greater investment in diagnostic and screening technologies.
Drug Screening Market- Competitive Landscape:
The drug testing market is characterized by a competitive landscape featuring a mix of large multinational corporations and specialized diagnostic companies. Leading players actively engage in strategic initiatives such as product innovation, mergers and acquisitions, partnerships, and geographic expansion to strengthen their market presence. Significant investments in research and development are focused on creating new assays, integrated testing platforms, and point-of-care devices capable of detecting a broader range of substances with higher accuracy. Service providers, including major reference laboratories, are expanding their testing capacities, improving turnaround times, and securing long-term contracts with large employers and government agencies. Meanwhile, smaller, innovative companies continue to challenge incumbents by introducing niche products and specialized testing services. Market differentiation is often achieved through advanced technology, comprehensive service offerings, regulatory compliance, and robust distribution networks.
Recent Developments:
- February 2024: Thermo Fisher Scientific announced the acquisition of Solventum’s Purification and Filtration business for $4.1 billion in cash. This acquisition aims to enhance Thermo Fisher’s life sciences portfolio, particularly supporting its bioprocessing segment with advanced purification and filtration technologies essential to various life science processes, including drug manufacturing.
- November 2023: Abbott expanded its global manufacturing capabilities by establishing a world-class facility in Kilkenny, Ireland. This investment strengthens Abbott’s manufacturing footprint and supports its extensive product range, including diagnostic solutions and medical devices, potentially boosting the availability and innovation of drug screening products in Europe.
- September 2023: Shimadzu Corporation launched a new High-Resolution Accurate Mass Library for Forensic Toxicology. This comprehensive database aids forensic laboratories by enabling more effective screening of substances such as drugs of abuse, psychotropic medications, pharmaceuticals, pesticides, and natural toxins, thereby enhancing drug detection and analytical capabilities.
- April 2023: Japan’s Metropolitan Police Department introduced its first basic test kit for identifying “date rape drugs.” While specific corporate details remain undisclosed, this initiative underscores domestic efforts to strengthen law enforcement’s ability to rapidly screen for drugs involved in drug-facilitated crimes.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DRUG SCREENING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- LabCorp
- Quest Diagnostics
- Abbott
- Thermo Fisher Scientific, Inc.
- Alfa Scientific Designs, Inc.
- OraSure Technologies, Inc.
- Siemens
- F. Hoffmann-La Roche Ltd
- MPD Inc.
- Shimadzu Corporation
GLOBAL DRUG SCREENING MARKET, BY PRODUCT & SERVICES - MARKET ANALYSIS, 2019 - 2032
- Equipment
- Liquid Analytical Instruments
- Rapid Testing Devices (RTD)
- Consumables
- Drug Screening
- Analytical Instruments
- Laboratory Services
GLOBAL DRUG SCREENING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032
- Oral Fluid or Saliva
- Breath
- Hair
- Urine
- Others
GLOBAL DRUG SCREENING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Workplace and Schools
- Criminal Justice Systems and Law Enforcement Agencies
- Drug Testing Laboratories
- Drug Treatment Centers
- Hospitals
- Personal Users
- Pain Management Centers
- Individual Users
- Colleges
GLOBAL DRUG SCREENING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Drug Screening Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Drug Screening Market Snippet By Product and Services
2.1.2. Drug Screening Market Snippet By Sample Type
2.1.3. Drug Screening Market Snippet By End User
2.1.4. Drug Screening Market Snippet by Country
2.1.5. Drug Screening Market Snippet by Region
2.2. Competitive Insights
3. Drug Screening Key Market Trends
3.1. Drug Screening Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Drug Screening Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Drug Screening Market Opportunities
3.4. Drug Screening Market Future Trends
4. Drug Screening Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Drug Screening Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Drug Screening Market Landscape
6.1. Drug Screening Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Drug Screening Market – By Product and Services
7.1. Overview
7.1.1. Segment Share Analysis, By Product and Services, 2024 & 2032 (%)
7.1.2. Equipment
7.1.3. Liquid Analytical Instruments
7.1.4. Rapid Testing Devices (RTD)
7.1.5. Consumables
7.1.6. Drug Screening
7.1.7. Analytical Instruments
7.1.8. Laboratory Services
8. Drug Screening Market – By Sample Type
8.1. Overview
8.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
8.1.2. Oral Fluid or Saliva
8.1.3. Breath
8.1.4. Hair
8.1.5. Urine
8.1.6. Other Samples
9. Drug Screening Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Workplace and Schools
9.1.3. Criminal Justice Systems and Law Enforcement Agencies
9.1.4. Drug Testing Laboratories
9.1.5. Drug Treatment Centers
9.1.6. Hospitals
9.1.7. Personal Users
9.1.8. Pain Management Centers
9.1.9. Individual Users
9.1.10. Colleges
10. Drug Screening Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Drug Screening Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Drug Screening Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Drug Screening Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Drug Screening Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Drug Screening Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product and Services, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Drug Screening Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. LabCorp
11.2.2. Quest Diagnostics
11.2.3. Abbott
11.2.4. Thermo Fisher Scientific, Inc.
11.2.5. Alfa Scientific Designs, Inc.
11.2.6. OraSure Technologies, Inc.
11.2.7. Siemens
11.2.8. F. Hoffmann-La Roche Ltd
11.2.9. MPD Inc.
11.2.10. Shimadzu Corporation
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
